2-amino-3-methyl-9h-pyrido(2,3-b)indole has been researched along with Precancerous Conditions in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasegawa, R; Ito, N; Iwasaki, S; Kim, DJ; Nagao, M; Ochiai, M; Shirai, T; Sugimura, T; Takahashi, S | 1 |
1 other study(ies) available for 2-amino-3-methyl-9h-pyrido(2,3-b)indole and Precancerous Conditions
Article | Year |
---|---|
Dose-dependent formation of preneoplastic foci and DNA adducts in rat liver with 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Topics: Animals; Carbolines; DNA; DNA Damage; Dose-Response Relationship, Drug; Glutathione Transferase; Imidazoles; Liver; Liver Neoplasms, Experimental; Male; Mutagens; Precancerous Conditions; Rats; Rats, Inbred F344 | 1992 |